PEPROMENE BIO

pepromene-bio-logo

PeproMene Bio is a virtual, privately funded biotech company .

#SimilarOrganizations #People #Website #More

PEPROMENE BIO

Industry:
Biotechnology Health Care

Founded:
2016-01-01

Address:
Irvine, California, United States

Country:
United States

Website Url:
http://www.pepromenebio.com

Total Employee:
1+

Status:
Active

Contact:
(949) 564-4085

Total Funding:
4 M USD

Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SSL By Default Google Font API LetsEncrypt Apple Mobile Web Clips Icon WordPress Font Awesome Wordpress Plugins Google Apps For Business


Similar Organizations

calimmune-logo

Calimmune

Calimmune is a clinical-stage gene therapy company.

Current Employees Featured

not_available_image

Larry Kwak
Larry Kwak Co-Founder & Chairman of Scientific Advisory Board @ PeproMene Bio
Co-Founder & Chairman of Scientific Advisory Board

bryan-kim_image

Bryan Kim
Bryan Kim CEO & President @ PeproMene Bio
CEO & President
2017-03-01

Founder


bryan-kim_image

Bryan Kim

not_available_image

Larry Kwak

Official Site Inspections

http://www.pepromenebio.com

  • Host name: 151.101.66.159
  • IP address: 151.101.66.159
  • Location: United States
  • Latitude: 37.751
  • Longitude: -97.822
  • Timezone: America/Chicago

Loading ...

More informations about "PeproMene Bio"

PeproMene Bio - Crunchbase Company Profile

PeproMene Bio is a virtual, privately funded biotech company . BAFFR CAR-T Cells: A novel CAR T cell therapy targeting BAFF-R for treating B cell malignancies and autoimmune diseases.See details»

About Us - Biotech Company in Irvine, CAPeproMene …

PeproMene Bio’s mission is to develop innovative therapies that will improve the lives of patients with cancer and immune disorders. And to bring cutting-edge therapies like BAFF-R CAR-T to market for patients with unmet medical needs.See details»

Pepromene Bio - LinkedIn

PeproMene Bio, Inc is a clinical-stage biotech company in Irvine, California. We are committed to developing novel therapies to treat cancers and immune disorders. Our CAR T cells targeting …See details»

Team - PeproMene Bio IncPeproMene Bio Inc

Founded in 1913, City of Hope is a world-renowned independent research and treatment center for cancer, diabetes and other life-threatening diseases, and is a leader in bone marrow transplantation and immunotherapy such as CAR T cell …See details»

PeproMene Bio - Org Chart, Teams, Culture & Jobs | The Org

View PeproMene Bio's up-to-date org chart, open roles, and culture details. Find executives, board members, teams, related companies, and more.See details»

PeproMene Bio Company Profile 2025: Valuation, Funding

PeproMene Bio General Information Description. Operator of a biotechnology company intended to develop novel immune-oncology therapies. The company offers services including …See details»

Contact Us - PeproMene Bio Inc

PeproMene Bio. Inc 15375 Barranca Pkwy. Suite A211 Irvine, CA 92618; Call us at 949-418-8860; Email us at info@pepromenebio.comSee details»

PeproMene Bio, Inc - VentureRadar

"PeproMene Bio, Inc is a private biotech company located Irvine, California. We are developing novel immune-oncology therapies, such as BAFF-R CAR-T therapy, based on novel antibodies.See details»

PeproMene Bio Company Profile | Management and Employees …

Www.pepromenebio.com . PeproMene Bio Profile and History. PeproMene Bio, Inc. is a clinical-stage private company developing treatments for critically ill patients. The company is …See details»

PeproMene Bio - Overview, News & Similar companies - ZoomInfo

PeproMene Bio contact info: Phone number: (714) 599-8077 Website: www.pepromenebio.com What does PeproMene Bio do? PeproMene Bio, Inc. is a clinical-stage private company …See details»

Pepromene Bio, Inc. Company Profile - Dun & Bradstreet

Find company research, competitor information, contact details & financial data for Pepromene Bio, Inc. of Irvine, CA. Get the latest business insights from Dun & Bradstreet.See details»

PeproMene Bio - Company Profile - Tracxn

Oct 26, 2024 PeproMene Bio ranks 489th among 2886 active competitors. 815 of its competitors are funded while 541 have exited. Overall, PeproMene Bio and its competitors have raised …See details»

PeproMene Bio - Products, Competitors, Financials, Employees ...

About PeproMene Bio. PeproMene Bio is a clinical-stage biotech company focused on developing novel therapies for cancer and immune disorders. The company's main offerings include BAFF …See details»

PeproMene Bio, Inc. and the Institute for Follicular Lymphoma ...

Dec 19, 2024 For more information on PeproMene Bio, Inc. visit pepromenebio.com, ... Related Organization(s) IFLI. Institute for Follicular Lymphoma Innovation. Contact Cision. 866-245-2317See details»

PeproMene Bio - Craft

PeproMene Bio has 1 employees at their 1 location and $4 m in total funding,. See insights on PeproMene Bio including office locations, competitors, revenue, financials, executives, …See details»

PeproMene Bio, Inc. - Drug pipelines, Patents, Clinical trials

Polyfunctionality correlates with a patient's remission lasting over 18 months with the CAR T cell therapy IRVINE, Calif., Aug. 7, 2024 /PRNewswire/ -- PeproMene Bio, Inc., a clinical-stage …See details»

PeproMene Bio, Inc. - Medium

IRVINE, Calif., Jan. 18, 2024 /PRNewswire/ — PeproMene Bio, Inc., a clinical-stage biotech company developing novel therapies to treat cancers and immune disorders, today announced …See details»

PeproMene Bio, Inc. Announces Complete Remission of the

IRVINE, Calif., Jan. 18, 2024 /CNW/ -- PeproMene Bio, Inc., a clinical-stage biotech company developing novel therapies to treat cancers and immune disorders, today announced that the …See details»

Pipeline - PeproMene Bio Inc

As more clinical data on the safety and efficacy of our investigational drugs become available, PeproMene will review and update its policy on Expanded Access. If you have questions about …See details»

PeproMene Bio, Inc. Announces Complete Remission of the …

IRVINE, Calif., Jan. 18, 2024 /PRNewswire/ — PeproMene Bio, Inc., a clinical-stage biotech company developing novel therapies to treat cancers and immune disorders, today announced …See details»

linkstock.net © 2022. All rights reserved